Eton Pharmaceuticals, Inc. - Common Stock (NQ:ETON)

55.36 +3.38 (+6.50%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eton Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Eton Pharmaceuticals Reports First Quarter 2024 Financial Results

May 09, 2024

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference

May 01, 2024

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

April 30, 2024

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

April 29, 2024

From Eton Pharmaceuticals

Via GlobeNewswire

Recap: Eton Pharmaceuticals Q4 Earnings ↗

March 14, 2024

Via Benzinga

Eton Pharmaceuticals Earnings Preview ↗

March 13, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 22, 2024

Via Benzinga

Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria

March 22, 2024

From Eton Pharmaceuticals

Via GlobeNewswire

ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023 ↗

March 14, 2024

ETON stock results show that Eton Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

March 14, 2024

From Eton Pharmaceuticals

Via GlobeNewswire

Is NASDAQ:ETON suited for growth investing? ↗

March 06, 2024

ETON PHARMACEUTICALS INC (NASDAQ:ETON) may be suited for growth investing, we'll explore why in this article.

Via Chartmill

Why the growth investor may take a look at NASDAQ:ETON. ↗

February 14, 2024

Exploring ETON PHARMACEUTICALS INC (NASDAQ:ETON)'s growth characteristics.

Via Chartmill

Evaluating NASDAQ:ETON for Growth Investment Opportunities. ↗

January 22, 2024

Exploring ETON PHARMACEUTICALS INC (NASDAQ:ETON)'s growth characteristics.

Via Chartmill

Earnings Scheduled For March 14, 2024 ↗

March 14, 2024

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

Via Benzinga

Eton Pharmaceuticals: Q3 Earnings Insights ↗

November 09, 2023

Via Benzinga

Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024

February 29, 2024

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation

February 21, 2024

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules

February 02, 2024

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results

November 09, 2023

From Eton Pharmaceuticals

Via GlobeNewswire

Gilead Sciences Tops Q3 Earnings And Revenue Estimates ↗

November 07, 2023

While Gilead has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

Via Talk Markets

Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

October 30, 2023

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone

October 04, 2023

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

August 23, 2023

From Eton Pharmaceuticals

Via GlobeNewswire

Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

August 11, 2023

Gainers Amyris, Inc. (NASDAQ: AMRS) shares jumped 179.1% to $0.1839. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy.

Via Benzinga

Topics Bankruptcy

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 11, 2023

Via Benzinga

Consolidated Water, Spectrum Brands, Arco Platform, Semler Scientific And Other Big Stocks Moving Higher On Friday ↗

August 11, 2023

U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

FSR Stock Alert: What to Know About the New Fisker Ronin EV ↗

August 11, 2023

Fisker (FSR) stock is in the news Friday after the company provided customers with more details about the upcoming Fisker Ronin Super GT EV.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 11, 2023

Via Benzinga

Why Is Cano Health (CANO) Stock Down 48% Today? ↗

August 11, 2023

Cano Health (CANO) stock is taking a beating on Friday after the healthcare company provided a business update in its latest earnings report.

Via InvestorPlace

Why is Yield10 Bioscience (YTEN) Stock Down 46% Today? ↗

August 11, 2023

Yield10 Bioscience (YTEN) stock is falling hard on Friday with heavy trading after a public share offering went into effect.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.